Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 2,566.11 | 2,748.38 | 2,808.33 | 2,883.50 |
| Operating Revenue | - | 2,566.11 | 2,748.38 | 2,808.33 | 2,883.50 |
| Cost Of Revenue | - | 744.59 | 828.68 | 774.55 | 817.80 |
| Gross Profit | - | 1,821.52 | 1,919.70 | 2,033.78 | 2,065.70 |
| Operating Expense | - | 1,435.06 | 1,571.77 | 1,653.57 | 1,697.79 |
| Research And Development | - | 412.40 | 469.33 | 443.06 | 450.19 |
| Selling General And Administration | - | 1,022.66 | 1,102.44 | 1,210.51 | 1,247.60 |
| Total Expenses | - | 2,179.65 | 2,400.45 | 2,428.12 | 2,515.59 |
| Operating Income | - | 386.46 | 347.93 | 380.21 | 367.91 |
| Total Operating Income As Reported | - | -658.56 | 279.84 | 380.21 | 266.21 |
| EBITDA | - | -551.11 | 398.18 | 532.66 | 367.02 |
| Normalized EBITDA | - | 494.12 | 475.25 | 519.26 | 514.25 |
| EBIT | - | -647.81 | 306.86 | 424.58 | 265.17 |
| Interest Income | - | 10.96 | 36 | 30.98 | 44.49 |
| Interest Expense | - | 14.17 | 14.04 | 13.81 | 18.51 |
| Net Interest Income | - | -3.21 | 21.96 | 17.18 | 25.98 |
| Other Income Expense | - | -1,045.23 | -77.07 | 13.39 | -147.23 |
| Interest Income Non Operating | - | 10.96 | 36 | 30.98 | 44.49 |
| Interest Expense Non Operating | - | 14.17 | 14.04 | 13.81 | 18.51 |
| Net Non Operating Interest Income Expense | - | -3.21 | 21.96 | 17.18 | 25.98 |
| Pretax Income | - | -661.98 | 292.82 | 410.78 | 246.66 |
| Tax Provision | - | 32.31 | -14.75 | 107.49 | 83.68 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -219.50 | -16.18 | 3.50 | -49.91 |
| Net Income Continuous Operations | - | -694.29 | 307.57 | 303.28 | 162.98 |
| Net Income From Continuing And Discontinued Operation | - | -694.29 | 307.57 | 303.28 | 162.98 |
| Net Income From Continuing Operation Net Minority Interest | - | -694.29 | 307.57 | 303.28 | 162.98 |
| Net Income | - | -694.29 | 307.57 | 303.28 | 162.98 |
| Net Income Common Stockholders | - | -694.29 | 307.57 | 303.28 | 162.98 |
| Net Income Including Noncontrolling Interests | - | -694.29 | 307.57 | 303.28 | 162.98 |
| Normalized Income | - | 131.44 | 368.45 | 293.39 | 260.30 |
| Diluted NI Availto Com Stockholders | - | -694.29 | 313.90 | 309.61 | 173.11 |
| Basic Average Shares | - | 126.78 | 122.50 | 114.94 | 102.36 |
| Diluted Average Shares | - | 126.78 | 140.15 | 131.72 | 124.11 |
| Reconciled Depreciation | - | 96.70 | 91.32 | 108.07 | 101.84 |
| Reconciled Cost Of Revenue | - | 744.59 | 828.68 | 774.55 | 817.80 |
| Total Unusual Items | - | -1,045.23 | -77.07 | 13.39 | -147.23 |
| Total Unusual Items Excluding Goodwill | - | -1,045.23 | -77.07 | 13.39 | -147.23 |
| Special Income Charges | - | -1,045.02 | -70.72 | 0 | -106.80 |
| Gain On Sale Of Business | - | 0 | -2.63 | 0 | -5.10 |
| Impairment Of Capital Assets | - | 1,045.02 | 68.09 | 0 | 101.70 |
| Gain On Sale Of Security | - | -0.21 | -6.35 | 13.39 | -40.43 |
| General And Administrative Expense | - | 312.26 | 343.24 | 353.95 | 332.77 |
| Other Gand A | - | 312.26 | 343.24 | 353.95 | 332.77 |
| Selling And Marketing Expense | - | 710.40 | 759.20 | 856.56 | 914.83 |
| Average Dilution Earnings | - | 0 | 6.34 | 6.32 | 10.12 |